申请人:The Rockefeller University
公开号:US20220185812A1
公开(公告)日:2022-06-16
Tri-cyclyl nitrogen-containing heterocyclic compounds
are disclosed. The compounds are inhibitors of human cGAS in interferon-producing cell types. They are thus useful as therapeutic agents for treating cGAS-related autoimmune diseases in humans.